Hepatitis C Virus – Identifying and Managing Resistance Associated Variants
Algolia Search
Schedule Telemedicine Consult with Dr. Gish Powered byTelemed2U
Powered byTelemed2U

Hepatitis C Virus – Identifying and Managing Resistance Associated Variants

Hepatitis C Treatment Challenges - A Tale of Two Epidemics

The introduction of direct-acting antiviral agents (DAAs) has transformed HCV treatment. While the majority treated are effectively cured after a regimen of typically 12 weeks, there is a significant minority who are either ineligible for certain DAA treatments, or who fail initial DAA treatment, due to either “baseline” or “emergent on-treatment mutations”.

Read article here:

https://jumpshare.com/v/SUJ3YmNhTshTLKbEmD9o